FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103124714> ?p ?o ?g. }

• W2103124714 abstract "Abstract Background The epidermal growth factor receptor (EGFR) is an established target for anti-cancer treatment in different tumour types. Two different strategies have been explored to inhibit this pivotal molecule in epithelial cancer development: small molecules TKIs and monoclonal antibodies. ErbB/HER-targeting by monoclonal antibodies such as cetuximab and trastuzumab or tyrosine-kinase inhibitors as gefitinib or erlotinib has been proven effective in the treatment of advanced NSCLC. Results In this study we explored the potential of combining either erlotinib with cetuximab or trastuzumab to improve the efficacy of EGFR targeted therapy in EGFR wild-type NSCLC cell lines. Erlotinib treatment was observed to increase EGFR and/or HER2 expression at the plasma membrane level only in NSCLC cell lines sensitive to the drug inducing protein stabilization. The combined treatment had marginal effect on cell proliferation but markedly increased antibody-dependent, NK mediated, cytotoxicity in vitro . Moreover, in the Calu-3 xenograft model, the combination significantly inhibited tumour growth when compared with erlotinib and cetuximab alone. Conclusion Our results indicate that erlotinib increases surface expression of EGFR and/or HER2 only in EGFR-TKI sensitive NSCLC cell lines and, in turns, leads to increased susceptibility to ADCC both in vitro and in a xenograft models. The combination of erlotinib with monoclonal antibodies represents a potential strategy to improve the treatment of wild-type EGFR NSCLC patients sensitive to erlotinib." @default.
• W2103124714 created "2016-06-24" @default.
• W2103124714 creator A5005558381 @default.
• W2103124714 creator A5006324667 @default.
• W2103124714 creator A5007784099 @default.
• W2103124714 creator A5009891179 @default.
• W2103124714 creator A5012454543 @default.
• W2103124714 creator A5023232493 @default.
• W2103124714 creator A5032386417 @default.
• W2103124714 creator A5041399505 @default.
• W2103124714 creator A5043298138 @default.
• W2103124714 creator A5043942287 @default.
• W2103124714 creator A5045373094 @default.
• W2103124714 creator A5048527327 @default.
• W2103124714 creator A5059886580 @default.
• W2103124714 creator A5065042718 @default.
• W2103124714 creator A5067317592 @default.
• W2103124714 creator A5071783009 @default.
• W2103124714 creator A5075729580 @default.
• W2103124714 creator A5081403345 @default.
• W2103124714 creator A5082672878 @default.
• W2103124714 creator A5083241126 @default.
• W2103124714 date "2012-12-01" @default.
• W2103124714 modified "2023-10-15" @default.
• W2103124714 title "Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines" @default.
• W2103124714 cites W1978068596 @default.
• W2103124714 cites W1998971866 @default.
• W2103124714 cites W2005909927 @default.
• W2103124714 cites W2007649418 @default.
• W2103124714 cites W2024086004 @default.
• W2103124714 cites W2024772577 @default.
• W2103124714 cites W2032998398 @default.
• W2103124714 cites W2039633811 @default.
• W2103124714 cites W2042278676 @default.
• W2103124714 cites W2044565900 @default.
• W2103124714 cites W2075451702 @default.
• W2103124714 cites W2089288294 @default.
• W2103124714 cites W2092138286 @default.
• W2103124714 cites W2097097666 @default.
• W2103124714 cites W2100912832 @default.
• W2103124714 cites W2101293925 @default.
• W2103124714 cites W2104748005 @default.
• W2103124714 cites W2105529705 @default.
• W2103124714 cites W2112660136 @default.
• W2103124714 cites W2125662786 @default.
• W2103124714 cites W2129432386 @default.
• W2103124714 cites W2129491055 @default.
• W2103124714 cites W2133208325 @default.
• W2103124714 cites W2133741785 @default.
• W2103124714 cites W2133757541 @default.
• W2103124714 cites W2136028687 @default.
• W2103124714 cites W2137600224 @default.
• W2103124714 cites W2138297714 @default.
• W2103124714 cites W2138604360 @default.
• W2103124714 cites W2140334822 @default.
• W2103124714 cites W2147684102 @default.
• W2103124714 cites W2154100643 @default.
• W2103124714 cites W2155933329 @default.
• W2103124714 cites W2168340462 @default.
• W2103124714 doi "https://doi.org/10.1186/1476-4598-11-91" @default.
• W2103124714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3577499" @default.
• W2103124714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23234355" @default.
• W2103124714 hasPublicationYear "2012" @default.
• W2103124714 type Work @default.
• W2103124714 sameAs 2103124714 @default.
• W2103124714 citedByCount "38" @default.
• W2103124714 countsByYear W21031247142013 @default.
• W2103124714 countsByYear W21031247142014 @default.
• W2103124714 countsByYear W21031247142015 @default.
• W2103124714 countsByYear W21031247142016 @default.
• W2103124714 countsByYear W21031247142017 @default.
• W2103124714 countsByYear W21031247142018 @default.
• W2103124714 countsByYear W21031247142019 @default.
• W2103124714 countsByYear W21031247142020 @default.
• W2103124714 countsByYear W21031247142021 @default.
• W2103124714 countsByYear W21031247142022 @default.
• W2103124714 countsByYear W21031247142023 @default.
• W2103124714 crossrefType "journal-article" @default.
• W2103124714 hasAuthorship W2103124714A5005558381 @default.
• W2103124714 hasAuthorship W2103124714A5006324667 @default.
• W2103124714 hasAuthorship W2103124714A5007784099 @default.
• W2103124714 hasAuthorship W2103124714A5009891179 @default.
• W2103124714 hasAuthorship W2103124714A5012454543 @default.
• W2103124714 hasAuthorship W2103124714A5023232493 @default.
• W2103124714 hasAuthorship W2103124714A5032386417 @default.
• W2103124714 hasAuthorship W2103124714A5041399505 @default.
• W2103124714 hasAuthorship W2103124714A5043298138 @default.
• W2103124714 hasAuthorship W2103124714A5043942287 @default.
• W2103124714 hasAuthorship W2103124714A5045373094 @default.
• W2103124714 hasAuthorship W2103124714A5048527327 @default.
• W2103124714 hasAuthorship W2103124714A5059886580 @default.
• W2103124714 hasAuthorship W2103124714A5065042718 @default.
• W2103124714 hasAuthorship W2103124714A5067317592 @default.
• W2103124714 hasAuthorship W2103124714A5071783009 @default.
• W2103124714 hasAuthorship W2103124714A5075729580 @default.
• W2103124714 hasAuthorship W2103124714A5081403345 @default.
• W2103124714 hasAuthorship W2103124714A5082672878 @default.
• W2103124714 hasAuthorship W2103124714A5083241126 @default.
• W2103124714 hasBestOaLocation W21031247141 @default.
• W2103124714 hasConcept C121608353 @default.

• next